Oral Primobolan & Winstrol Lean Muscle Cycle + PCT (Driada Medical)

Clinical Overview: Advanced Non-Injectable Cutting & Vascularity Protocol

Engineered specifically for athletes seeking lean tissue accrual without hypodermic administration, this protocol combines pharmaceutical-grade Primobolan Tablets (Methacetos 25 mg) with Stanos 10 mg (Stanozolol). Methenolone acetate exhibits high anabolic specificity with virtually zero aromatase interaction, preserving lean intracellular nitrogen while preventing estrogenic fluid retention. Concurrently, Stanozolol binds with high affinity to Sex Hormone-Binding Globulin (SHBG), drastically displacing endogenous bound steroids and dramatically elevating circulating free Methenolone serum concentrations for accelerated muscle protein synthesis and density.

Because both compounds exhibit distinct non-aromatising androgenic profiles, this stack is among the most effective curated Oral-Only Steroid Cycles for achieving a chiselled, vascular physique during severe caloric deficits. Rather than facing heavy aromatisation or synthetic progestogenic toxicity, the user experiences clean structural definition. The inclusion of pharmaceutical Enclomilad ensures rapid pituitary LH and FSH resurgence post-cycle, protecting newly established skeletal muscle mass.

Complete Kit Package Components

• 2 × Methacetos 25 mg (Methenolone acetate) - Driada | 50tabs | 25 mg/tab
• 1 × Stanos 10 mg (Stanozolol, Winstrol) | 100 Tabs
• 1 × Enclomilad 12.5 mg (Enclomiphene citrate) - Driada | 50tabs | 12,5 mg/tab

6-Week Cycle & PCT Dosage Administration Schedule

Administration Guidelines, Pharmacokinetics & Endocrine Recovery

To maximize bio-availability, divide your daily Methacetos dose into 50–75 mg across two to three equal administrations with dietary lipids to support non-17-alpha-alkylated intestinal absorption. Administer Stanos at 20–30 mg daily split evenly every 8 hours to offset its short half-life and maintain stable cellular saturation. Since Stanozolol is C17-alpha-alkylated, incorporating baseline hepatoprotective supplements like TUDCA or NAC is clinically recommended. Athletes transitioning from advanced Steroid Cycles will appreciate the zero-water-retention profile and rapid kinetic clearance of this oral pairing.

Begin your post-cycle recovery immediately at Week 7 without delay, as short-ester Methenolone and oral Winstrol clear metabolic pathways within 24 to 36 hours. Administer Enclomilad (Enclomiphene citrate) at 12.5 mg every morning for 4 continuous weeks (Weeks 7–10). Unlike traditional Clomid blends, Enclomiphene acts as a pure estrogen antagonist at the hypothalamic-pituitary axis without unwanted estrogenic isomer agonism, rapidly restoring natural luteinizing hormone and endogenous testosterone production.

Key Physique & Physiological Advantages

• Potent SHBG Downregulation: Stanozolol significantly lowers Sex Hormone-Binding Globulin, multiplying circulating free, bioactive Methenolone concentrations to maximize nitrogen retention and myofibrillar hypertrophy.
• Zero Aromatisation & Zero Water Retention: Neither Methenolone acetate nor Stanozolol converts to estradiol, completely eliminating the risk of gynecomastia and sub-fascial fluid accumulation for a hard, vascular finish.
• 100% Needle-Free Compliance: Complete dry lean-mass cycle engineered entirely in precise oral solid-dose tablets from Driada Medical, eliminating injection discomfort and localized tissue fibrosis.
• Targeted HPTA Rebound with Enclomiphene: The inclusion of Enclomilad provides selective pituitary stimulation without the mood disturbances or thrombotic risks commonly associated with legacy zuclomiphene compounds.